ArticleComputational and structural biotechnology journal2024
MM-DRPNet: A multimodal dynamic radial partitioning network for enhanced protein-ligand binding affinity prediction.
Article in Computational and structural biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Critical Artifacts Improve Reproducibility of Protein-Ligand Binding Affinity Prediction Models on CASF-2016.Journal of chemical information and modeling · 2026Article
- Structure-Aware Compound-Protein Affinity Prediction via Graph Neural Networks with Group Lasso Regularization.Computational and structural biotechnology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of drug-target binding affinity remains a fundamental challenge in contemporary drug discovery. Despite significant advances in computational methods for protein-ligand binding affinity prediction, current approaches still face substantial limitations in prediction accuracy. Moreover, the prevalent methodologies often overlook critical three-dimensional (3D) structural information, thereby constraining their practical utility in computer-aided drug design (CADD). Here we present MM-DRPNet, a multimodal deep learning framework that enhances binding affinity prediction by integrating protein-ligand structural information with interaction features and physicochemical properties. The core innovation lies in our dynamic radial partitioning (DRP) algorithm, which adaptively segments 3D space based on complex-specific interaction patterns, surpassing traditional fixed partitioning methods in capturing spatial interactions. MM-DRPNet further incorporates molecular topological features to comprehensively model both structural and spatial relationships. Extensive evaluations on benchmark datasets demonstrate that MM-DRPNet significantly outperforms state-of-the-art methods across multiple metrics, with ablation studies confirming the substantial contribution of each architectural component. Source code for MM-DRPNet is freely available for download at https://github.com/Bigrock-dd/MMDRPv1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.